Knockdown of RNA-binding protein IMP3 suppresses oral squamous cell carcinoma proliferation by destabilizing E2F5...

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• RNA-binding proteins (RBPs) are dysregulated in various cancers, including oral squamous cell carcinoma (OSCC).
• Insulin-like growth factor 2 mRNA-binding protein 3 (IMP3) plays a role in OSCC progression, but its regulatory mechanisms are unclear.
• Understanding IMP3's role in mRNA fate is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the molecular mechanism of IMP3-mediated regulation of E2F5 expression in OSCC.
• To determine the functional significance of the IMP3/E2F5 axis in OSCC progression.
• To evaluate IMP3/E2F5 as potential therapeutic targets for OSCC.

Main Methods:

• Analysis of IMP3 and E2F5 expression in OSCC tissues and cell lines using immunohistochemistry, qRT-PCR, and Western blot.
• Silencing IMP3 expression with siRNAs in OSCC cell lines (SCC-25, SCC-4).
• RNA immunoprecipitation (RIP) assay to confirm IMP3 binding to E2F5 mRNA.
• In vitro and in vivo (xenograft mouse models) functional studies.

Main Results:

• A positive correlation between IMP3 and E2F5 expression was observed in OSCC.
• IMP3 directly binds to E2F5 mRNA, regulating its stability and protein expression.
• Silencing IMP3 led to decreased E2F5 levels, inhibited cell proliferation, and reduced tumor growth in vivo.
• IMP3 and E2F5 are involved in regulating cell proliferation and cell cycle in OSCC.

Conclusions:

• IMP3 regulates E2F5 mRNA stability, impacting cell proliferation and cell cycle in OSCC.
• The IMP3/E2F5 pathway is a key mechanism in OSCC progression.
• IMP3 and E2F5 represent promising therapeutic targets for oral squamous cell carcinoma.